REPL Competitors & Alternatives
Compare Replimune Group Inc with similar stocks in the same industry
Biotechnology
REPL
Main Stock$13.45
Tradestie Score
63
Market Cap
$328.62M
Analyst Upside
+45.0%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$9.25
|
$1.29B | - | 40 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$26.01
|
$1.29B | - | 67 | Compare |
|
ARDX
Ardelyx, Inc.
|
$3.38
|
$1.29B | - | 64 | Compare |
|
ZYME
Zymeworks Inc.
|
$25.96
|
$1.28B | - | 59 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$5.56
|
$1.27B | - | 60 | Compare |
|
YDES
YD Bio Limited Ordinary Shares
|
$7.81
|
$1.26B | - | 36 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 54 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$7.35
|
$1.22B | - | 44 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$8.21
|
$1.18B | - | 45 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$46.21
|
$1.17B | - | 63 | Compare |
More REPL Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2836)
228 stocks in this industry